Cited by 1,394Smoking Behavior and CessationGlobal Cancer Incidence and ScreeningHealthcare Systems and Public Health

Mortality from tobacco in developed countries: indirect estimation from national vital statistics.

Peto, R., Boreham, J., Lopez, A.D., Thun, M., Heath, C.·1992·The Lancet

Abstract

Prolonged cigarette smoking causes even more deaths from other diseases than from lung cancer. In developed countries, the absolute age-sex-specific lung cancer rates can be used to indicate the approximate proportions due to tobacco of deaths not only from lung cancer itself but also, indirectly, from vascular disease and from various other categories of disease. Even in the absence of direct information on smoking histories, therefore, national mortality from tobacco can be estimated approximately just from the disease mortality statistics that are available from all major developed countries for about 1985 (and for 1975 and so, by extrapolation, for 1995). The relation between the absolute excess of lung cancer and the proportional excess of other diseases can only be approximate, and so as not to overestimate the effects of tobacco it has been taken to be only half that suggested by a recent large prospective study of smoking and death among one million Americans. Application of such methods indicates that, in developed countries alone, annual deaths from smoking number about 0.9 million in 1965, 1.3 million in 1975, 1.7 million in 1985, and 2.1 million in 1995 (and hence about 21 million in the decade 1990-99: 5-6 million European Community, 5-6 million USA, 5 million former USSR, 3 million Eastern and other Europe, and 2 million elsewhere, [ie, Australia, Canada, Japan, and New Zealand]). More than half these deaths will be at 35-69 years of age: during the 1990s tobacco will in developed countries cause about 30% of all deaths at 35-69 (making it the largest single cause of premature death) plus about 14% of all at older ages. Those killed at older ages are on average already almost 80 years old, however, and might have died soon anyway, but those killed by tobacco at 35-69 lose an average of about 23 years of life. At present just under 20% of all deaths in developed countries are attributed to tobacco, but this percentage is still rising, suggesting that on current smoking patterns just over 20% of those now living in developed countries will eventually be killed by tobacco (ie, about a quarter of a billion, out of a current total population of just under one and a quarter billion).

Integrity signals

Registry

Crossref · 10.1016/0140-6736(92)91600-d

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Peto, R., Boreham, J., Lopez, A. D., Thun, M., & Heath, C.
Affiliations
  • University of Oxford (GB)
  • American Cancer Society (US)
Venue
The Lancet
Publisher
Elsevier BV
Published
1992-05
Volume
339
Issue
8804
Pages
1268-1278
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2114616454
Cited by
1,394
References
13
Citations by year
2026: 7 · 2025: 15 · 2024: 19 · 2023: 23 · 2022: 37 · 2021: 33 · 2020: 32 · 2019: 22 · 2018: 35 · 2017: 29 · 2016: 38 · 2015: 44 · 2014: 41 · 2013: 41 · 2012: 48
FWCI
25.83
Type
journal article
Language
en
Open access
closed
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords
smoking-related mortality, cigarette smoking, lung cancer, vascular disease, indirect estimation, excess mortality, premature mortality, age-specific mortality, life expectancy, developed countries
MeSH terms
Adult, Aged, Aged, 80 and over, Cardiovascular Diseases, Data Interpretation, Statistical, Europe, Female, Humans, Life Expectancy, Lung Diseases, Male, Middle Aged, Neoplasms, Population Surveillance, Prospective Studies, Risk, Smoking, United States

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review